Join us for a Webinar on Wednesday, 6th May 2020 with Nina Lauterbach (Field Application Scientist, Omixon) who will be talking about the crucial differences between NGS and Sanger sequencing. She is going to highlight the benefits and challenges of NGS based HLA typing, and what tools are needed in the software to properly analyze the data.
Nina Lauterbach, FAS, Omixon
Agenda:
🔸 Brief History
🔸 Sanger sequencing vs. NGS
🔸 Benefits and challenges of NGS
🔸 Tools in the NGS analysis software – HLA Twin™ 🔸 Summary
🔸 Q&A
Please note that participation in this educational program provides Continued Education Credits (CECs) which are accredited by the American Board of Histocompatibility and Immunogenetics (ABHI).
We are looking forward to seeing you remotely on our next sessions in the near future. If you have any questions, please contact us directly at sales@omixon.com
